<DOC>
	<DOCNO>NCT00793624</DOCNO>
	<brief_summary>The primary objective study ass long-term efficacy safety daily treatment BI 1744 CL inhalation solution ( 5 10 mcg ) deliver via RespimatÂ® inhaler , patient COPD .</brief_summary>
	<brief_title>Safety Efficacy BI 1744 CL Patients With Chronic Obstructive Pulmonary Disease I</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Olodaterol</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<criteria>Inclusion criterion : 1 . All patient must diagnosis chronic obstructive pulmonary disease must meet follow spirometric criterion : postbronchodilator FEV1 &lt; 80 % predict normal ( ECSC ) postbronchodilator FEV1/FVC &lt; 70 % Visit 1 2 . Male female patient , 40 year age old 3 . Patients must current exsmokers smoke history 10 pack year : Exclusion criterion : 1 . Patients clinically relevant abnormal baseline haematology , blood chemistry , urinalysis ; patient SGOT &gt; x2 ULN , SGPT &gt; x2 ULN , bilirubin &gt; x2 ULN creatinine &gt; x2 ULN 2 . Patients history asthma and/or total blood eosinophil count great 600/mm3 3 . Patients thyrotoxicosis , paroxysmal tachycardia ( &gt; 100 beat per minute ) 4 . Patients history myocardial infarction within 1 year screen visit , unstable lifethreatening cardiac arrhythmia , hospitalization heart failure within past year , know active tuberculosis , malignancy patient undergone resection , radiation therapy chemotherapy within last five year , lifethreatening pulmonary obstruction , cystic fibrosis , clinically evident bronchiectasis , significant alcohol drug abuse 5 . Patients undergone thoracotomy pulmonary resection 6 . Patients treat oral betaadrenergics oral corticosteroid medication unstable dos ( i.e. , less six week stable dose ) dose excess equivalent 10 mg prednisone per day 20 mg every day . 7 . Patients regularly use daytime oxygen therapy one hour per day . 8 . Patients complete pulmonary rehabilitation program six week prior screen visit ( Visit 1 ) patient currently pulmonary rehabilitation program 9 . Pregnant nursing woman 10 . Women childbearing potential use two effective method birth control ( one barrier one nonbarrier ) .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>